SARS-CoV-2 Proteins Induce
COVID-19
IFN-γ
IFNG
SARS-CoV-2
Th1
Th17
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
12 Nov 2020
12 Nov 2020
Historique:
received:
09
10
2020
revised:
02
11
2020
accepted:
09
11
2020
entrez:
17
11
2020
pubmed:
18
11
2020
medline:
18
11
2020
Statut:
epublish
Résumé
The outbreak of the SARS-CoV-2 virus in December 2019 has caused the deaths of several hundred thousand people worldwide. Currently, the pathogenesis of COVID-19 is poorly understood. During the course of COVID-19 infection, many patients experience deterioration, which might be associated with systemic inflammation and cytokine storm syndrome; however, other patients have mild symptoms or are asymptomatic. There are some suggestions that impaired cellular immunity through a reduction in Th1 response and
Identifiants
pubmed: 33198287
pii: vaccines8040673
doi: 10.3390/vaccines8040673
pmc: PMC7712722
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Narodowe Centrum Nauki
ID : 2015/18/E/NZ5/00733
Références
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
Rom J Intern Med. 2012 Jan-Mar;50(1):13-8
pubmed: 22788089
J Immunol. 2012 Sep 15;189(6):3034-42
pubmed: 22891280
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Arthritis Rheumatol. 2017 Jun;69(6):1135-1143
pubmed: 28217930
J Immunol. 2012 Sep 1;189(5):2348-55
pubmed: 22844122
BMC Bioinformatics. 2008 Nov 01;9:465
pubmed: 18976492
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Future Virol. 2012 Jun;7(6):593-608
pubmed: 23024699
BMC Infect Dis. 2014 Jun 20;14:346
pubmed: 24950742
Lett Appl Microbiol. 2020 May;70(5):342-348
pubmed: 32060933
Can J Infect Dis Med Microbiol. 2006 Nov;17(6):330-6
pubmed: 18382647
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Open Biol. 2019 Jul 26;9(7):190109
pubmed: 31337278
Cells. 2020 Jul 03;9(7):
pubmed: 32635226
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
J Leukoc Biol. 2016 Nov;100(5):1213-1223
pubmed: 27256574
Vaccines (Basel). 2020 Sep 24;8(4):
pubmed: 32987794
Nat Immunol. 2007 Sep;8(9):950-7
pubmed: 17676044
J Immunol. 2009 Oct 15;183(8):5301-10
pubmed: 19783685
Lancet. 2003 Jan 4;361(9351):51-9
pubmed: 12517470
J Med Virol. 2020 Jul;92(7):755-769
pubmed: 32237160
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
PLoS Pathog. 2009 Aug;5(8):e1000406
pubmed: 19714239
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726
pubmed: 32647056
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Lancet Infect Dis. 2005 Nov;5(11):718-25
pubmed: 16253889
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
J Virol. 1992 Apr;66(4):1977-84
pubmed: 1312614
Cell Mol Immunol. 2016 Jan;13(1):3-10
pubmed: 26189369
Cell. 2000 Mar 17;100(6):655-69
pubmed: 10761931